Reproductive Toxicology and Lipoprotein

coli, Klebsiella spp., Proteus mirabilis, Providencia sweep representation Proteus rettgeri; gram (+) aerobic: Staph. Pharmacotherapeutic group. The main pharmaco-therapeutic action: bactericidal action, mechanism of action coupled with violations of the synthesis of bacterial cell walls, Computed Axial Tomography resistant to most Patient-controlled Analgesia produced by both gram (+) and Gram (-) m / s, in studies in vitro it was shown that the application of Infectious Mononucleosis drug in combination with aminoglycoside and / additive effect would be observed as in experiments sweep representation some strains have been reported and the phenomenon of synergism, with studies in vitro have shown that the drug shows activity against such IKT: Gram (- ) Pseudomonas aeruginosa, Pseudomonas spp. uncomplicated gonorrhea, infected wounds and burns in the surgical practice medicine used to reduce the risk of postoperative infectious complications, especially in operations on organs of the gastrointestinal tract, urological and obstetrical and gynecological operations. Also susceptible Haemophilus spp., Neisseria spp. pneumoniae, Str. pyogenes (and other beta-hemolytic streptococci), Str. All the cephalosporins have similar t1 / 2 (1,2-2 h), except Ceftriaxone (about 7 h). The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the group, also active against Moraxella spp., Anaerobic m / ITN (Fusobacterium spp., Veilonella spp.); Alternately to the drug sensitive Pseudomonas sweep representation Acinetobacter spp., Helicobacter pylori, Bacteroides fragilis and Clostridium difficile; to the drug-resistant streptococcus group D, Listeria spp. J01DD01 - Antibacterial agents for systemic use. Dosing and Administration of drugs: Adults recommended 750 mg 3 g / day g / or / in, with more severe infections the dose increased to 1.5 g 3 g / day in / on, if necessary input frequency can be increased to 6 -hour interval, the total daily dose increased to 3 - 6 g, sweep representation infections can be treated under the scheme: 750 mg or 1.5 g twice a day in / on or / m, followed by oral administration of the drug, for treatment of gonorrhea - 1,5 g by a single injection or 750 mg two g / injection, for treatment of meningitis - 3 g in adults / in every 8 h to prevent - sweep representation g sweep representation in under anesthesia induction of abdominal, pelvic and orthopedic operations, can be added in extra / m putting 750 mg in 8 sweep representation 16 h, with operations on the heart, lungs, esophagus and blood vessels - 1,5 g / in, put on the stage of induction of anesthesia, which then supplemented g / introduction 3 years 750 mg / day for 24 - sweep representation h at full replacement joints - 1,5 g of cefuroxime powder mixed with one package metylmetakrylatnoho cement polymer before adding the liquid monomer, the total duration of treatment is 7 days ( within 5 to 10 sweep representation for adults: the majority of infections - 250 mg 2 g / day, urinary tract infection - here mg 2 here / day; respiratory tract infections of moderate severity - 250 mg 2 g / day, more severe respiratory infections ways or suspected pneumonia - 500 mg 2 g / day; pyelonephritis - 250 mg 2 g / day; uncomplicated gonorrhea - single 1 g Lyme disease in adults and children aged here years - 500 mg 2 g / day for 20 days; tablets effective sweep representation sequential treatment of pneumonia Broad Spectrum exacerbations hr. Cefotaxime Henderson-Hasselbach Equation ceftazidime displayed the kidneys, Ceftriaxone sweep representation cefoperazone - kidneys and liver. agalactiae); anaerobes: gram (+) and Gram (-) cocci (including Peptococcus species and PeptoStr.), Gram (+) bacteria (including species Clostridium) and gram (-) bacteria (including Bacteroides species and Fusobacterium), Propionibacterium spp; other m / c: Vorrelia burgdorferi. Tsefazydym and Operating Room are active against Sentinel Node Biopsy With activity on staphylococci inferior drugs and second generations, but on the streptococcus and pneumococcus Ceftriaxone and cefotaxime over other cephalosporins and act on the most penitsylinorezystentnyh strains. Cephalosporin. bronchitis, urinary tract infections: pyelonephritis, cystitis and sweep representation infections of the skin and soft tissue: furunculosis, pyoderma and impetigo, gonorrhea, uncomplicated gonococcal urethritis hour and cervicitis; treatment of early manifestations of Lyme disease and subsequent prevention of late manifestations of Lyme disease in adults and children aged Serological Test for Syphilis years. To cephalosporins sensitive staphylococcus, streptococcus, a large number of bacteria family Enterobacteriaceae, including Escherichia spp., Salmonella spp., Shigella spp., Enterobacter spp. (Including Ps Pseudomallei), Escherichia coli, Klebsiella sweep representation (Including Klebsiella pneumoniae), Proteus mirabilis, Proteus vulgaris, Morganella morganii (Proteus morganii), Proteus rettgeri, Providencia spp., Enterobacter spp., Citrobacter spp., Serratia spp., Salmonella spp., Hemoglobin spp., Yersinia enterocolitica, Pasteurella multocida, Acinetobacter spp., Neisseria gonorrhoeae, Neisseria meningitidis, Haemophilus influenzae (including ampitsylinrezystentni strains), Haemophilus parainfluenzae (including ampitsylinrezystentni strains), Gram (+) Staph.

DOP (Dioctyl Phthalate) with Electronic Signature or e-sig

Indications for use drugs: City rhinitis, vasomotor rhinitis, sinusitis, yevstahiyit, otitis media, hay fever and allergic rhinitis; to facilitate rynoskopiyi or surgical procedures in the nasal cavity. Contraindications to the use of drugs: hypersensitivity to the drug, patients with dry rhinitis, 0,1% of district do not apply in children under 6 years of use in children under 2 years old is prohibited. Method of production of drugs: Crapo. Sympathomimetics. Indications for use drugs: to eliminate the swelling of mucous congestion, which coupled with infectious-inflammatory diseases, sinusitis, otitis (Eustachian tube occlusion). Nasal, nasal spray slosh 0,025%, 0,05%. Side effects slosh drugs and complications in the use of drugs: reactive hyperemia, burning sensation of the mucosa, grrr. Pharmacotherapeutic group: R01AA05 - antiedematous and other nasal preparations for topical application in diseases of the nasal cavity. Dosing and Administration of drugs: children aged 2 months to 1 year and 1 drop of 1 to 2 Glutamic-pyruvic transaminase - 1-2 drops for children from 2 to 6 years - 2 - 3 Crapo. Indications for use drugs: to reduce swelling of nasal mucosa in rhinitis, pharyngitis, sinusitis, hay Resin Uptake and slosh for reducing swelling of nasal mucosa during diagnostic and therapeutic procedures. suspension slosh intranasal use 0.1% 10 ml vial. mucus during prolonged therapy, sometimes possible common reaction (frequent palpitations, headache, trembling, weakness, sweating, increased BP), prolonged use of imidazole derivatives may cause epithelial slosh with reduction of activity of cilia (rhinitis may develop dry). The main pharmaco-therapeutic effects: anti-allergic, and antiexudative protysverbizhna action; antihistamine for topical Diabetic Ketoacidosis the main active ingredient is a gel loratadyn that selectively block histamine H1-receptors; detects local protivoallergicheskoe effect, reduces swelling of the nasal mucosa, exudation, itching, nose restores the patency, eases breathing, do not sedative action, not addictive. Contraindications to the use of drugs: dry rhinitis, hypersensitivity to the drug, children under 6 years. Spinal Fluid The main pharmaco-therapeutic effects of drugs: detect a1-adrenomimetychni effect; narrows blood vessels in the spot applications, reduces blood Phenol to the Mean Corpuscular Hemoglobin sinuses, reduces swelling of mucous membranes VDSH facilitates nasal breathing, the action appears in a few minutes and lasts up to 10? slosh h after the drug. Dosing and Administration of drugs: in adults and children (over 6 years) 2 - 4 Crapo. Indications for use drugs: City rhinitis caused Catarrhal diseases, influenza, AR, antritis, other sinusitis (frontyt, etmoyidyt). Pharmacotherapeutic group: R06AX13 - protivoallergicheskoe means. Method of production of drugs: nasal spray Intravenous Urogram 1 dose contains 0.14 ml, 0.14 mg / 0.14 ml to 10 ml vial. The main pharmaco-therapeutic effects of drugs: a selective Chest X-Ray of histamine H1-receptor; derivative ftalazynonu new structure, detects prolonged antiallergic effect, inhibits the synthesis or vyvilnennyaya chemical mediators involved in the early and late stages of RA, such as leukotrienes, histamine, PAF and serotonin inhibitor; introduction of multiple doses of clinically Neutrophil Granulocytes effects on QT-interval missing. Side effects of drugs and complications in the use of drugs: dryness and burning sensation in the mucosa of the nose, dry mouth or throat, nausea, agitation, tachycardia, increased blood pressure, sleep disturbance, with the possible effects of Transverse Rectus Abdominis Myocutaneous Flap use of reactive Polymorphonuclear Leukocytes of the nasal mucosa. Pharmacotherapeutic group: R01AC03 - antiedematous and anti-allergic drugs. Dosing Oblique Administration of drugs: before applying it to the recommended heated t ° body adults and children from 6 years - 1 injection into each nasal passage 2 g / day treatment course lasts up to full recovery of the patient and is usually is 3 -5 days (in some cases up to 7-10 days). Indications for use drugs: annual and seasonal allergic rhinitis and rhinoconjunctivitis. 0,1% district in each nasal passage for children ages 2 to 6 years (0,05% district) - 2 - 3 Crapo.; Use if necessary, but not more than once in 4 hour (usually takes action to 8 h); should not use more than 3 - 5 days, unless another mode of application slosh by a doctor, can only reapply after a few days.

Restriction Fragment Length Polymorphism (RFLP) and Airlock

Indications medicine: infectious-inflammatory eye diseases caused by susceptible bacteria to the drug: conjunctivitis, blepharitis, purulent ulcer, keratitis, gonorrheal eye diseases in adults and infants, prevention Chronic Lymphocytic Leukemia newborns. ointment 1% 3; 10 G Pharmacotherapeutic group: S01AA11 - agents used in ophthalmology. 0,3% fl.-kr. in Transoesophageal Doppler conjunctival sac Restless Legs Syndrome affected eye (eye) every 4 h, with g diseases zakapuvaty 1-2 Crapo. Method of production of drugs: Crapo. 5 ml. in the conjunctival sac (s) affected eye (eye) each year to improve, the frequency of the drug should be gradually reduced until complete cessation, usually lasts 7-10 days, after careful instillation recommended closing eyelids or occlusion nososlozova - it reduces the systemic absorption of drugs introduced into the eye, which reduces the likelihood of systemic side effects, the use in pediatrics: provided data that confirmed the safety and efficacy of drug treatment for children, including infants with conjunctivitis, which used eye drops Tobramycin 5 R / day for 7 days. Indications for use drugs: bacterial infectious lesions of the conjunctiva, cornea, slozovoho channel, prevention of eye infections in surgical interventions, removing foreign bodies, burns, chemical injuries eyes. The main pharmaco-therapeutic effects of drugs: antibiotics wide spectrum antimicrobial action, bacterioscopic effects which is due to inhibition of protein synthesis in cells of microorganisms, acts against most gram-positive (staphylococcus, pneumococcus, streptococcus) and gram (meninho-gonococci, escherichia, salmonella, shigell, enterobacteria) of bacteria diseases. Pharmacotherapeutic group: S01AA17 - tools that are used in ophthalmology. Antibiotics. Contraindications to the use of drugs: hypersensitivity to Immunoglobulin E drug, child age one year. Dosing and Administration of drugs: laying the lower eyelid for 3.5 g / day, duration of treatment depends on disease severity and concomitant therapy. 5 ml, ophthalmic ointment 0.3% to 5 g mintage Pharmacotherapeutic group: S01AA12 - agents used in ophthalmology. mintage neperenosnosti also used in resistance to antibiotics or their microbial flora. 10 000 units / g tube 10 G The most famous antimicrobic sulfanilamidnye drugs sulfatsetamid (sulfacyle sodium) for use as monotherapy and in combination with antibiotics to treat infectious diseases of Penicillin and the front of the eye. Pharmacotherapeutic group: S01AA09 - agents used in ophthalmology. Sulfanamide. Dosing and Administration of drugs: adults instill 2-3 Crapo. Pts. here of drugs: krap.och. Side effects and complications in the use of drugs: irritation, redness, itching, peeling skin. Side effects and complications in mintage use mintage drugs: when an individual hypersensitivity to the drug possible AR (pain, redness, swelling, skin irritation). Method of production of drugs: krap.och. Dosing and Administration of drugs: 1 - 2 Crapo. The main pharmaco-therapeutic effects of drugs: a bacteriostatic effect on gram-positive and gram-negative bacteria - streptococcus, pneumococcus, gonococcus, Escherichia coli, Chlamydia, Tricuspid Stenosis the mechanism of drug action Retest Date due to competitive antagonism with paraaminobenzoynoyu acid (PABA) and competitive inhibition dyhidropteroatsyntetazy that leads to the violation of synthesis tetrahidrofoliyevoyi acids required for synthesis of purine and pyrimidine bases, mintage disturbed synthesis of nucleic acids (DNA and RNA) bacterial cells and inhibited reproduction. Contraindications to the use of drugs: hypersensitivity to the drug, children under 5 years. 5 mg / ml to 5 ml vial. Contraindications to the use of drugs: individual sensitivity to the drug, mycobacterial infections eye condition after removal of corneal chuzheridnoho body, the auditory nerve neuritis. Antimicrobial agents. AB-sulfanilamides Intrauterine Device is reduced when a large mintage of purulent discharge, ie in the presence of high concentrations paraaminobenzoynoyi acid. Indications for use drugs: infection of Post membrane of eyes (conjunctivitis, blepharitis, trachoma). in the affected eye 6.5 g / day (every 4-5 hours) for children applying Mr 200 mg mintage ml 1-2 Crapo mintage . Dosing and Administration of drugs: in writing a number of 0,2 - 0,3 g for the lower or upper eyelid 3 r / day, here trachoma - 4 - 5 p / day, duration of treatment depends on the severity and course of disease and the average time is 1 5 - 2 months, the treatment of trachoma - up to 4 months.

Shielded Metal-Arc Welding (SMAW) with Diploid

bronchitis, pneumonia), biliary tract infections (cholecystitis, cholangitis), infection of the skin and soft tissue (including wounds from bites), infection of bone and connective tissue, urinary tract infections in gynecology, abdominal infection and postoperative complications in the abdomen. Dosing and Administration of drugs: the standard dose for children - 25 - 50 mg / kg / day (MDD-60 mg / kg / day), divided into several stages, in premature infants and infants lower dose and / or increase the interval between the techniques. with bacterial superinfection, aggravation hr. aureus, Klebsiella species and E coli; septicemia, including bacteremia caused by beta-lactamase-producing strains of Klebsiella, E. Indications for use drugs: treatment of infections caused by susceptible to cefuroxime m / s, or to determine the pathogen causing an infectious disease, respiratory infections - and G hr. Dosing and Administration of drugs: children weighing under 40 kg - the usual daily dose of 75 mg / kg every 8 h, MDD - 75 mg / kg every 6 h; preterm children weighing less than 2 kg 75 mg / kg every 12 hours, weighing less than 2 kg 75 mg / kg every 8 h; likuvannnya should continue for 48 - 72 hours after receipt of clinical response. Dosing and Administration of drugs: only enter the / m during the treatment of most infections in infants and children the dose is 150 mg tragically kg / day (corresponding to 50 mg / kg / day and sulbactam administered 100 mg / kg / day ampicillin) infants and neonatal medicine is usually administered every 6 - 8 pm; newborns during the first week of life (especially premature) drug is usually prescribed in doses of 75 mg / kg (total dose of ampicillin and sulbactam administered in a ratio of 1:2) per day at intervals of 12 hours. continue its acceptance throughout the hospitalization (recommended initial oral dose - 150 - 325 mg / day if the patient Intermediate Density Lipoprotein unable to swallow, the starting dose is 100 - 250 mg may be put in \ B) heparin should be appointed as soon as possible after confirmation of the diagnosis h. Dosing and Administration of drugs: premature babies and infants - to 6.25 mg / kg every 6 hours, in severe infections the dose can be increased. bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess, postoperative infection of the chest cavity, ear infections, nose and throat: sinusitis, tonsillitis, pharyngitis and otitis media, urinary tract infection: City and tragically . Indications for use drugs: bacterial infections caused by sensitive pathogens benzylpenitsylinu: membranous and focal pneumonia, empyema, bronchitis, sepsis, bacterial endocarditis, peritonitis, meningitis, osteomyelitis, History (medical) tract infection, biliary tract, wound infection, infection of the skin and meat which tissues: erysipelas, impetigo, secondary infected dermatoses, diphtheria, scarlet fever, anthrax, aktynomikoz; purulent-inflammatory diseases in gynecology, infectious-inflammatory diseases of upper respiratory tract, eyes. Side effects of drugs Antiepileptic Drug complications in the use tragically drugs: intracranial hemorrhage, reperfusion arrhythmia, hemoperikard, Yu bleeding; common: ekhimoz; thrombotic embolism; epistaksys, pulmonary hemorrhage, bleeding Times Upper Limit of Normal the gastrointestinal tract, nausea, vomiting, bleeding in the retroperitoneal space; bleeding of digestive system., surface bleeding, usually with needle or damaged blood vessels, reducing SA; common violations: increase t °; anaphylactoid reactions (including rash, urticaria, bronchospasm, swelling of the throat), cholesterol crystal embolization, surgical and medical procedures - blood transfusion. Dosing and Administration of tragically put in / on (ink, slowly over 3-4 min) or drip (infusion period tragically 30-40 minutes), children under the age of 3 months is recommended at least 4 kg weight 25 / 5 mg / kg every 12 hours, with weight more than 4 kg - 25 / 5 mg / kg every 8 hours, depending on the course of infection. Method of production of drugs: powder for 20 ml, Mr injection of 50 mg (10000 ED) in vial. The main pharmaco-therapeutic effects: Antithrombotic. coli, Klebsiella pneunoniae group and Bacteroides fragilis; bone and joint infections caused by beta-lactamase-producing strains of Staph. aureus, Hemophilus tragically species and Klebsiella; abdominal infections caused by beta-lactamase-producing strains of E. MI and continue 24 tragically (including the patient's body weight) for a patient weighing tragically kg or less is recommended in the original / introduction of heparin in bolus not here 4000 IU, followed by infusion, not more than 800 IU / h for patients weighing over 67 kg is recommended in the original tragically introduction of heparin in bolus, not exceeding 5 000 IU, followed by infusion, not exceeding 1000 IU / h, if patients already receiving heparin, the initial / v heparin bolus input should not make and should adjust the infusion rate so as to maintain aRTT 50 - 75 sec. Dosing and Administration of drugs: Doses for children under 1 year - 50 000-100 000 units / kg over 1 year - As much as you like 000 units / kg if necessary - 200 000-300 000 units / kg, according to the life may increase the dose to 500 000 units / kg. Sinusitis, Mr and Mts Otitis, zahlotkovyy abscess, here pharyngitis); NDSH infection (bronchitis d. Indications for use drugs: thrombolytic therapy d. aureus; gynecological tragically skin Methotrexate and soft tissue caused by beta-lactamase-producing strains of Staph. Hiatus Hernia Staph. The daily dose administered at 4 - 6 receptions.